Clinical Trial Shows POEM Procedure is Less Invasive and More Effective for Achalasia Treatment

Achalasia Achalasia is a rare disease which causes damage to the nerves in the esophagus. Patients have difficulty swallowing, heartburn, and chest pain. Many also experience weight loss. While there is…

Continue Reading Clinical Trial Shows POEM Procedure is Less Invasive and More Effective for Achalasia Treatment
The Results of This Phase 3 PKAN Clinical Trial are a Major Letdown
RyanMcGuire / Pixabay

The Results of This Phase 3 PKAN Clinical Trial are a Major Letdown

According to a story from BioSpace, the biopharmaceutical company Retrophin, Inc., recently released the topline results from its phase 3 clinical trial. This clinical trial was testing the company's drug…

Continue Reading The Results of This Phase 3 PKAN Clinical Trial are a Major Letdown

The Isaac Foundation has Turned to Television to Get Their Mucopolysaccharidosis Message Heard

The Isaac Foundation The Isaac Foundation was established by a man named Andrew McFadyen. He created the organization in 2007 in honor of  his son who is diagnosed with the rare…

Continue Reading The Isaac Foundation has Turned to Television to Get Their Mucopolysaccharidosis Message Heard

Expectations For This Clinical Trial Were to Slow Down ALS Progression; Instead it Reversed One Man’s Symptoms

  According to a recent article published in News NWA, in 2017 Mark Bedwell, of Fort Smith, Arkansas had been told that based upon the rapid progression of his amyotrophic…

Continue Reading Expectations For This Clinical Trial Were to Slow Down ALS Progression; Instead it Reversed One Man’s Symptoms
The Drug Fasenra has Earned Orphan Drug Designation to Treat Eosinophilic Esophagitis
Pexels / Pixabay

The Drug Fasenra has Earned Orphan Drug Designation to Treat Eosinophilic Esophagitis

According to a story from Check Orphan, the biopharmaceutical company AstraZeneca recently announced that its drug benralizumab (marketed as Fasenra) has earned Orphan Drug designation from the US Food and…

Continue Reading The Drug Fasenra has Earned Orphan Drug Designation to Treat Eosinophilic Esophagitis
Close Menu